Summary
CERM 3S17 (mociprazine), a new anti-emetic compound, was administered orally to six beagle dogs at 10 mg/kg b.i.d. for four days. Unconjugated urinary metabolites were identified by GC-MS analysis against synthesized reference compounds, after solvent extraction, purification by TLC and concentration. Twenty one metabolites were identified indicating the following biotransformations: N-dephenylation followed by reactions on the exposed secondary amine such as methylation and acetylation;and parahydroxylation on the phenyl ring, and monohyrdoxylation on the cyclohexyl ring in different positions. The parahydroxylation on the phenyl ring was confirmed by NMR analysis. Some reactions on the secondary amine were unexpected, such as N-formylation. N-dephenylation and N-formylation were confirmed not to be artifacts. The role of the para-hydroxyl intermediate was proved to be essential for the N-dephenylation after intravenous administration of meta- and para-hydroxylated derivatives of CERM 3517 to five beagle dogs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
CERM (1975): US Patent 3, May 20, 884, 923.
Pognat J.F., Enreille A., Chabard JL., Busch N., Berger J.A. (1986): N-dephenylation of CERM 3517 (mociprazine) in Beagle dogs, a mass spectrometric determination. Drug Metab. Dispos., 14,147–154.
Batten P.L., Hathway D.E. (1977): Dephenylation of N-phenyl-2-naphthylamine in dogs and its possible oncogenic implications. Br. J. Cancer, 22, 342.
Anderson M.M., Mitchum R.H., Beland F.A. (1982): Hepatic microsomal metabolism and macromolecular binding of the antioxydant, N-phenyl-2-naphthylamine. Xenobiotica, 12, 31–43.
Heykants J., Pardoel L., Janssen P.A.J. (1971): On the distribution and metabolism of azaperone (R 1929) in the rat and pig. Arzneimittelforschung, 21, 982–984.
Moore R.M. Jr., Woolf B.S., Stein H.P., Thomas A.W., Finklea J.K. (1977): Metabolic precursors of a known human carcinogen. Science, 195, 344.
Sanjuan M., Rovei V., Dow J., Strolin Benedetti M. (1983): Mass spectrometric studies of the metabolites of niaprazine. Int J. Mass Spectrom. Ion Phys., 48, 93–96.
Sano M., Moroi R., Ono K. (1974): Metabolites of Dj-1461 in rat urine. Chem. Pharm. Bull., 22, 3006–3009.
Knapp D.R. (1978): In: Blau K., King GS. Eds. Handbook of Derivatives for Chromatography. Heyden and Son Ltd, pp. 116.
Mulder G.J., Hinson J.A., Gillette J.R. (1978): Conversion of the N-O-glucuronide and N-O-sulfate conjugates of N-hydroxyphenacetin to reactive intermediates. Biochem. Pharmacol., 27, 1641–1649.
Schraven E., Koss F.W., Keck J., Beisenherz G. (1967): Excretion, isolation and identification of the metabolites of Bisoluon®. Eur. J. Pharmacol., 1, 445–451.
Kopitar Z., Jauch R., Hankwitz R., Pelzer H. (1973): Species differences in metabolism and excretion of Bromhexine in mice, rats, rabbits, dogs and man. Eur. J. Pharmacol., 21, 6–10.
Wright G.J., Leeson G.A., Zeiger A.V., Lang J.F. (1973): The absorption, excretion and metabolism of perhexiline maleate by the human. Postgrad. Med. J., 49, Suppl. 3, 8–15.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Enreille, A., Pognat, J.F., Galmter, M.J. et al. N-Dephenylated and N-phenyl urinary metabolites of mociprazine (CERM 3517) in beagle dogs after oral administration. A mass spectrometric determination. European Journal of Drug Metabolism and Pharmacokinetics 16, 161–172 (1991). https://doi.org/10.1007/BF03189953
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189953